PAN Solutions Revenue and Competitors
Estimated Revenue & Valuation
- PAN Solutions's estimated annual revenue is currently $362.5k per year.
- PAN Solutions's estimated revenue per employee is $72,500
Employee Data
- PAN Solutions has 5 Employees.
- PAN Solutions grew their employee count by 67% last year.
PAN Solutions's People
Name | Title | Email/Phone |
---|
PAN Solutions Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.4M | 6 | 0% | N/A | N/A |
#2 | $0.4M | 6 | 0% | N/A | N/A |
#3 | $42.1M | 264 | 6% | N/A | N/A |
#4 | $0.6M | 8 | 0% | N/A | N/A |
#5 | $1.6M | 18 | 6% | N/A | N/A |
#6 | $1.3M | 15 | -6% | N/A | N/A |
#7 | $0.4M | 6 | -14% | N/A | N/A |
#8 | $0.6M | 8 | 0% | N/A | N/A |
#9 | $2M | 27 | -27% | $4.9M | N/A |
#10 | $1.4M | 16 | 0% | N/A | N/A |
What Is PAN Solutions?
PAN Solutions (Pharmaceutical Accountability Network) was founded in 2012 by Dr. David Nockley and Dr. Henry Aftewicz. As licensed, practicing pharmacists in the state of Pennsylvania, Drs. Nockley and Aftewicz have been on the frontline of our country's biggest, deadliest epidemic, prescription drug abuse, since 2000. Through their work in virtually every sector of pharmacy, and battling this deadly, rapidly growing epidemic on a daily basis, Drs. Nockley and Aftewicz began the daunting task of developing a system that would seamlessly streamline the prescribing and dispensing of ALL prescription medication. The objective: to provide both prescribers and pharmacists with all relevant prescription data instantly, prior to prescribing and dispensing, without having to change their current workflow systems. The result was Scriptcheck, the nation's FIRST and ONLY REAL-TIME prescription drug monitoring system.
keywords:N/AN/A
Total Funding
5
Number of Employees
$362.5k
Revenue (est)
67%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $16.5M | 110 | 8% | N/A |